Multimodal genome‐wide meta‐analysis of brain amyloidosis reveals heterogeneity across CSF, PET, and pathological amyloid measures

Authors :: Keith A. Johnson
Carlos Cruchaga
Murat Bilgel
Richard Mayeux
Logan Dumitrescu
Timothy J. Hohman
Corinne D. Engelman
C. Dirk Keene
Gerard D. Schellenberg
Julie A. Schneider
Walter A. Kukull
Rachel F. Buckley
Angela L. Jefferson
Emily R. Mahoney
David A. Bennett
Henrik Zetterberg
Eric B. Larson
Derek B. Archer
Susan M. Resnick
Gary W. Beecham
William J. Jagust
Reisa A. Sperling
Thomas J. Montine
Sterling C. Johnson
Kaj Blennow
Yuetiva Deming
Source :: Alzheimer's & Dementia. 16
Publication Year :: 2020
Publisher :: Wiley, 2020.

Subjects :: Amyloid
Epidemiology
business.industry
Health Policy
Amyloidosis
Disease
medicine.disease
Bioinformatics
Genome
Psychiatry and Mental health
Cellular and Molecular Neuroscience
Developmental Neuroscience
Meta-analysis
medicine
Neurology (clinical)
Geriatrics and Gerontology
business
Pathological

Full Text Access

Tools